- A
- A
- A
Slash Your Cancer Risk With Phytonutrients
Why you can't rely on diet to lower your cancer risk
There are two problems with relying on diet to lower your cancer risk: First, most of us can't or won't eat enough cabbage and tomato-family vegetables to give us the protection that we need.
Unfortunately, a lot people positively despise vegetables like cabbage, broccoli, Brussels sprouts and cauliflower! But even people who love these vegetables find it hard to get them at restaurants that they eat at during the work week and on supermarket shelves at certain times of the year. Even when these vegetables are available, their content of cancer-fighting phytonutrients varies with the soil, time of harvest, etc.
The second problem with relying on diet alone to lower your cancer risk is that many foods are loaded with carcinogens. Vegetables and fruits in particular are usually loaded with pesticides, making it questionable whether eating more does more harm than good. The reality is that relying solely on diet to prevent cancer is playing Russian roulette with your health. Fortunately, there is a healthy and effective alternative.
You need to look for supplements that contain di-indolylmethane — the more active ingredient found in the cabbage-family of foods. Because di-indolylmethane is so much more potent than indole-3-carbinol -- about ten times as active -- you need much less.
Di-indolylmethane is a better choice in other ways too. Indole-3-carbinol needs to be "activated" by your digestive tract. It more readily degrades when exposed to air, light, and high temperatures. Di-indolylmethane does not need to be activated and is much more stable. When your life is at risk, you want the most potent cancer fighter money can buy. Why take a chance on less than the best?
To get the vital vegetable nutrients your body needs to slash your risk of contracting a debilitating and disfiguring cancer, dietary supplements may help. For most of us it's one of the best ways of insuring that we never hear the three most terrifying words in the English language, "You have cancer."
* The test we are referring to is called the 2/16a-hydroxyestrone-ratio test. This can be done using a single urine specimen, collected at any time of the day or (for women) any time of the menstrual cycle. The test is $89 plus shipping and handling. Contact Meridian Valley Laboratories at 1-253-859-8700 or online at http://www.meridianvalleylab.com.
Editor's Note:
The natural health solutions described in this article are available through many on-line retailers including those listed below. By clicking these links you help support the important alternative health research we provide.
Visit www.amazon.com – a great way to find competitive deals on supplements offered by many different manufacturers.
Visit www.hfn-usa.com – when commitment to quality and freshness is important, this factory direct solution is preferred by many of our readers.
This article is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a physician before embarking on a dietary supplement program.
References
-
Cancer Mortality Rates, Changes from 1973 to 1992 (Ages Under 65), National Cancer Institute, 12/4/00,www.nci.nih.gov/public/factbk95/cund65.htm
-
Ibid.
-
Op. cit., National Cancer Institute.
-
Giovannuci, E. Tomatoes, tomato-based products, lycopene, and cancer: review of the epidemiologic literature. J Natl Cancer Inst1999; 91(4): 317-331.
-
Laino, C. Tomatoes may treat prostate cancer. www.msnbc.com/news/258430.asp
-
Zumoff, B. Hormonal profiles in women with breast cancer. Obstet Gyn Clin North America 1994; 21 (4): 751-772.
-
Cavalieri, EL, et al. Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997; 94: 10937-10942, emphasis added.
-
Bell, MC, et. al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gyn Oncol 2000; 78 (2): 123-129.
-
M Protich, D Tsvetkov, B Nalbanski, et al. Clinical trial of the preparation of Tribestan in infertile men, Akush Ginekol 1983; 22(4): 326-9.
-
F Kumanov, E Bozadzhieva, M Andreeva, et al. Clinical trial of the drug "Tribestan." Savr Med 1982;4:211-5.
-
IV Viktorov, AL Kaloyanov, L Lilov, eta al. Clinical investigation on Tribestan in males with disorders in the sexual function. Med-Biol Inf 1982. Cited in Zarkova S. Tribestan: Experimental and Clinical Investigations. Chemical Pharmaceutical Research Institute, Sofia, 1983.